Transaction Summary

  • On December 2nd, 2022, the leading open access (“OA”) medical journal publisher Cureus announced its full acquisition by global academic publishing company Springer Nature Group
  • The acquisition enhances Springer Nature’s leading OA portfolio, complementing its over 20 year commitment to OA. Cureus’ innovative business model, enables medical professionals, without access to research grant funds, to be able to publish peer
    reviewed articles OA
  • Offical Press Release (transaction details are not disclosed)

Overview of Cureus

  • Founded in Silicon Valley in 2009, Cureus emerged as scalable platform within the OA medical publishing sector with a philosophy emphasising scientific credibility over perceived impact
  • Cureus runs an online medical community covering 61 specialties
  • Cureus has published over 32,000 articles to date and generates currently 3 million monthly article views from 1 million unique
  • In December, authors published over 1,200 articles in the digital Cureus journal
  • More than 20,000 authors have published on Cureus with an article acceptance rate of 51% and average submission to publication
    time of just 37 days
  • The company was founded by John Adler, Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology (Emeritus) at
    Stanford University together with his co-founder Alexander Muacevic, Medical Director of the European Radiosurgery Center in
    Munich and Professor of Neurosurgery at the University of Munich, who will continue to lead Cureus

NOAH Advisors’ Role

  • NOAH Advisors worked closely with Cureus exploring strategic options to position the company for the next phase of growth